Drugs and Medicine

Entecavir

Question: DNA (real time PCR) 2.2X10 7 IU/ML. Do not want to take entecavir;What will happen. Whatis highest/lowestlevel? I have no discomfort at all.Is 10 7 just in the middle between the highest and the lowest. What level is the highest and what level is the lowest ?

Answer: Liver can't really feel pain or discomfort. It gets bloated, fatty or harden and detected by ultra sound. The count is from 0-10 (as what my doc told me). Yours is 7. This shows that the virus is very active, which might lead to fibrosis or cirrhosis (liver hardening if you are a heavy drinker), or cancer or hep C. These are the reasons of why I started my medication. I had delayed it for 2 years trying to bet on my luck by controlled diet, a second and a third opinion from the specialist. Because I do not know your age and gender, so I can only tell you if you are male and over 40, please do not hesitate to consult a specialist. Liver condition can be beyond control if it rapidly get worse in 6 month time. Being stubborn and let your illness get worse is very unwise and stupid. Good luck.

 


Entecavir Related Products and News

Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ...

MarketWatch (press release)
... Therapeutics for Hepatitis B 1056.7.1 Entecavir plus Adefovir Combination Therapy 1056.7.2 Tenofovir plus Emtricitabine Combination Therapy 1066.7.3 Pegylated Interferon Alfa-2a + Adefovir 1066.8 Promising Molecules under Development - Therapeutics ...
 

Solid Q1 performance for BMS as new launches boost sales

PMLiVE
Cancer drug Sprycel (dasatinib), rheumatoid arthritis treatment Orencia (abatacept) and Baraclude (entecavir) for hepatitis B allalso achieved growth, each recording Q1 revenues of more than $200m. ?This first quarter performance continues to ...
 

Also in the press

OnMedica
... Johnson & Johnson's Simponi (golimumab) for arthritis (27000 pounds), Bristol-Myers Squibb's Baraclude (entecavir) for hepatitis B (14000 pounds per QALY) and Elan/Biogen Idec's Tysabri (natalizumab) for multiple sclerosis (35000 pounds per QALY).
 

Bristol-Myers 1st-qtr in line with expectations, as net income jumps 12%

The Pharma Letter
The Sustiva (efavirenz) HIV franchise generated $386 million, up 13%, while hepatitis B drug Baraclude (entecavir) grew18% to $325 million. Rheumatoid arthritis drug Orencia (abatacept) was up 28% at $254 million. However, HIV therapy Reyataz ...
 

Hepatologia - post?py 2011

Medycyna Praktyczna
Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir. J.Viral Hepat., 2011; 18: e432-e438 12. Marcellin P., Buti M., Gane EJ i wsp.: Five years of treatment with tenofovir DF for ...